DOJ announces settlement to allow CVS-Aetna merger
The Department of Justice’s Antitrust Division today announced a settlement that would allow CVS Health and Aetna to proceed with their proposed merger if Aetna divests its Medicare Part D prescription drug plans to WellCare. The settlement was filed in federal court as part of a civil antitrust lawsuit brought by the department and state attorneys general from California, Florida, Hawaii, Mississippi and Washington over competitive concerns with the merger. If approved by the court, the settlement would resolve those concerns, the agency said.
Related News Articles
Headline
The AHA Sept. 17 urged the Department of Health and Human Services’ Office of Inspector General to further scrutinize policies and practices by certain…
Headline
The Centers for Medicare & Medicaid services Sept. 10 announced the opening of a 60-day public comment period regarding its proposed plan for new data…
Headline
Hospitals and health systems are seeing significant increases in administrative costs, including due to burdensome practices by commercial insurers that often…
Headline
The Centers for Medicare & Medicaid Aug. 15 announced it negotiated lower prices with drug makers for 10 high-cost, sole-source drugs, with the new prices…
Headline
The AHA, joined by five other national hospital associations, Aug. 14 filed an amicus brief urging the Supreme Court to correct the Department of Health and…
Headline
The AHA Aug. 13 commented to the Medicare Payment Advisory Commission in anticipation of the commission’s 2024-2025 cycle. The AHA urged MedPAC to carefully…